Kruppel-like factor 4 improves obesity-related nephropathy through increasing mitochondrial biogenesis and activities

Lingwei Jin1, Hanyang Ye1, Min Pan1

  • 1Department of Nephrology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Insights

Renal Kruppel-like factor 4 (KLF4) protects against obesity-related kidney disease by maintaining mitochondrial function and suppressing inflammation. Lower KLF4 levels correlate with poorer kidney function in obesity.

Area of Science:

  • Nephrology
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Obesity is linked to metabolic complications, including kidney disease.
  • Kruppel-like factor 4 (KLF4) is implicated in acute kidney injury, but its role in chronic kidney disease (CKD) is unclear.

Purpose of the Study:

  • To investigate the role of renal KLF4 in obesity-induced kidney injury.
  • To elucidate the mechanisms by which KLF4 influences obesity-related nephropathy.

Main Methods:

  • High-fat diet-induced obesity mouse model.
  • In vitro studies using palmitic acid-treated mouse endothelial cells.
  • Analysis of human renal biopsies and plasma samples.

Main Results:

  • Decreased renal KLF4 levels correlated with impaired kidney function (elevated creatinine and blood urea nitrogen).
  • KLF4 overexpression reduced inflammation in palmitic acid-treated cells.
  • KLF4 attenuated obesity-induced renal dysfunction, structural changes, and inflammation.
  • KLF4 preserved renal mitochondrial biogenesis and function, counteracting obesity-induced mitochondrial dysfunction.
  • In humans, renal KLF4 levels negatively correlated with creatinine and positively with creatinine clearance.

Conclusions:

  • Renal KLF4 plays a protective role in obesity-related nephropathy.
  • KLF4 and mitochondrial function are key determinants of energy homeostasis in CKD.

Related Concept Videos